Results

Background/Objectives
The time from diagnosis to overall mortality for patients who died ranged from 5 days to 3,255 days (about 9 years), with the median time-to-death of 1,071 days (approximately 3 years). It indicates that among patients who died, 50% of them died within 3 years of diagnosis.  Survival probability drops from 100% at diagnosis to slightly lower than 80% at around 10 years and 9 months after diagnosis.  Survival probability for African Americans was lower than that for Caucasians. 
Conclusions
 The older the patient at diagnosis, the worse the overall survival. 2 Underuse of potentially curative local therapy among these men may partly explain the observed differences in PCa survival across age strata. 2,3  Marriage is well known to have a positive impact on patient survival across many malignancies. 4, 5 It has been argued that married men are more likely to undergo early screening, comply with treatment, and have a social support. 6  Literature shows that smoking is associated with aggressive PCa, and thus decreases survival in PCa patients. 7  Having no health insurance is a barrier to receipt of timely and high-quality medical care, including preventive services. 8  Surgical treatment is reserved for patients with localized prostate cancer and who are projected to have a long life expectancy. 9,10  Men with poorly differentiated, undifferentiated, or unknown tumor grades tend to have a more advanced stage of disease at the time of prostate cancer diagnosis. 11,12  Advanced diagnostic techniques and the emergence of new therapies may explain the increased survival among men diagnosed with PCa in recent years. 13  Long-term survival depends, in part, on risks posed by existing comorbidity because patients with significant comorbidities are not likely to derive expected benefits from treatment. 14, 15 
